Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure. Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.
Looking for a particular Stem Cell Theranostics employee's phone or email?
The Stem Cell Theranostics annual revenue was $6 million in 2026.
Rebecca Stanley is the Executive Director of Stem Cell Theranostics.
4 people are employed at Stem Cell Theranostics.
Stem Cell Theranostics is based in Redwood City, California.
The NAICS codes for Stem Cell Theranostics are [32, 325, 3254].
The SIC codes for Stem Cell Theranostics are [283, 28].